Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HARROW, INC.HROW · Entity 4740 | Director | June 14, 2024 | June 17, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HARROW, INC.
Report date June 14, 2024 · Filed June 17, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| RSUSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 8,347 |
Reported balance
After 2024-06-14 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-06-14 · Grant · Acquired 8,347 · Balance 8,347 F1: The Restricted Stock Units were received as a compensatory award for services rendered or to be rendered. F2: Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units were received as a compensatory award for services rendered or to be rendered.
F2: Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 14, 2024 Filed Jun 17, 2024 22:00 UTC | HARROW, INC. HROW · Entity 4740 | GrantRSU · Derivative | 8,347 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-024194 · ownership.xml · derivative · entry 1 Makary Martin A. · CIK 0001921566 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,347 Underlying: Common Stock · 8,347 shares Expires not disclosed F1 · security: The Restricted Stock Units were received as a compensatory award for services rendered or to be rendered. F2 · derivative.exercise_date: Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service. F2 · derivative.expiration_date: Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service. Read SEC document |
| August 14, 2023 Filed Aug 15, 2023 11:30 UTC | HARROW, INC. HROW · Entity 4740 | PurchaseCommon Stock | 20,000 | $16.92 | $338,400.00 |
DisclosureSEC source: 0001493152-23-028830 · ownership.xml · nonDerivative · entry 1 Makary Martin A. · CIK 0001921566 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.60 to $17.23, inclusive. The reporting person undertakes to provide to Harrow Health, Inc. ("Harrow"), any security holder of Harrow, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 20:30 UTC | HARROW, INC. HROW · Entity 4740 | GrantRSU · Derivative | 7,744 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-022258 · ownership.xml · derivative · entry 1 Makary Martin A. · CIK 0001921566 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,744 Underlying: Common Stock · 7,744 shares Expires not disclosed F1 · security: The Restricted Stock Units were received as a compensatory award for no consideration. F2 · derivative.exercise_date: Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service. F2 · derivative.expiration_date: Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service. Read SEC document |
| December 21, 2022 Filed Dec 23, 2022 12:01 UTC | HARROW, INC. HROW · Entity 4740 | PurchaseCommon Stock | 25,000 | $13.37 | $334,250.00 |
DisclosureSEC source: 0001493152-22-036394 · ownership.xml · nonDerivative · entry 1 Makary Martin A. · CIK 0001921566 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.30 to $13.43, inclusive. The reporting person undertakes to provide to Harrow Health, Inc. ("Harrow"), any security holder of Harrow, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 21:49 UTC | HARROW, INC. HROW · Entity 4740 | GrantRSU · Derivative | 13,123 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-016471 · ownership.xml · derivative · entry 1 Makary Martin A. · CIK 0001921566 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,123 Underlying: Common Stock · 13,123 shares Expires not disclosed F1 · security: The Restricted Stock Units were received as a compensatory award for no consideration. F2 · derivative.exercise_date: Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service. F2 · derivative.expiration_date: Award of Restricted Stock Units vests quarterly in equal installments over a one-year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.